The pharmaceuticalization of sexual risk: Vaccine development and the new politics of cancer prevention

Social Science and Medicine

Volumn 101, Issue , 2014, Pages 155-165

  Mamo, Laura ^a   Epstein, Steven ^b  

^a SAN FRANCISCO STATE UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cancer prevention; Pharmaceuticalization; Sexual risk; Sexualization; Vaccines

Indexed keywords

CANCER VACCINE; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; WART VIRUS VACCINE;

CANCER; DISEASE PREVALENCE; HEALTH RISK; HEPATITIS; PHARMACEUTICAL INDUSTRY; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; VACCINE;

ARTICLE; ATTITUDE TO HEALTH; CANCER IMMUNIZATION; CANCER PREVENTION; CANCER RISK; DISEASE ASSOCIATION; DRUG INDUSTRY; DRUG MARKETING; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK BEHAVIOR; HOMOSEXUAL MALE; HUMAN; INFECTION PREVENTION; INFECTION RISK; LIFESTYLE; LIVER CANCER; NONHUMAN; PAPILLOMAVIRUS INFECTION; PHARMACEUTICALIZATION; PHARMACOLOGICAL SCIENCE; PUBLIC HEALTH SERVICE; SEXUAL BEHAVIOR; SEXUAL PRACTICE; SEXUAL TRANSMISSION; SOCIOLOGY; UTERINE CERVIX CANCER; VACCINE PRODUCTION; VIRUS CARCINOGENESIS; WART VIRUS;

UNITED STATES;

HEPATITIS B VIRUS; HUMAN PAPILLOMAVIRUS;

CANCER PREVENTION; PHARMACEUTICALIZATION; SEXUAL RISK; SEXUALIZATION; VACCINES;

ADOLESCENT; ADULT; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; LIVER NEOPLASMS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POLITICS; RISK; RISK-TAKING; SEXUAL BEHAVIOR; SEXUALITY; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84894051697     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2013.11.028     Document Type: Article

References (90)

1. Abraham J. Pharmaceuticalization of society in context: theoretical, empirical and health dimensions. Sociology 2010, 44:603-622.
2. Abraham J. The sociological concomitants of the pharmaceutical industry and medications. Handbook of medical sociology 2010, 290-308. Vanderbilt University Press, Nashvhille, Tennessee. C.E. Bird, P. Conrad, A.M. Fremont, S. Timmermans (Eds.).
3. American Cancer Society Cancer prevention and early detection: Facts and figures 2005, ACS, Atlanta.
4. Anderson S.P. Gay foundation, plasma firm team up to tame hepatitis 1982, 21. The Advocate.
5. Aronowitz R.A. Gardasil: a vaccine against cancer and a drug to reduce risk. Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions 2010, 21-38. The Johns Hopkins University Press, Baltimore, Maryland. K. Wailoo, J. Livingston, S. Epstein, R. Aronowitz (Eds.).
6. Bell S.E., Figert A.E. Medicalization and pharmaceuticalization at the intersections: looking backward, sideways and forward. Social Science & Medicine 2012, 75:775-783.
7. Biehl J. Pharmaceutical governance. Global pharmaceuticals: Ethics, markets, practices 2006, Duke University Press, Durham, North Carolina. A. Petryna, A. Lakoff, A. Kleinman (Eds.).
8. Biehl J. Drugs for all: the future of global AIDS treatment. Medical Anthropology 2008, 27:99-105.
9. Bisht M., Bist S.S. Human papilloma virus: a new risk factor in a subset of head and neck cancers. Journal of Cancer Research and Therapeutics 2011, 7:251-255.
10. Blumberg B.S. Hepatitis B: The hunt for a killer virus 2002, Princeton University Press, Princeton.
11. Boshart M., Gissmann L., Ikenberg H., Kleinheinz A., Scheurlen W., zur Hausen H. Anew type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. The EMBO Journal 1984, 3:1151-1157.
12. Braun L., Phoun L. HPV vaccination campaigns: masking uncertainty, erasing complexity. Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions 2010, 39-60. The Johns Hopkins University Press, Baltimore, Maryland. K. Wailoo, J. Livingston, S. Epstein, R. Aronowitz (Eds.).
13. Busfield J. Pills, power, people: sociological understandings of the pharmaceutical industry. Sociology 2006, 40:297-314.
14. Carpenter L.M., Casper M.J. Global intimacies: innovating the HPV vaccine for women's health. WSQ: Women's Studies Quarterly 2009, 37:80-100.
15. Casper M.J., Carpenter L.M. Sex, drugs, and politics: the HPV vaccine for cervical cancer. Sociology of Health & Illness 2008, 30:886-899.
16. Centers for Disease Control and Prevention Recommendation of the immunization practices advisory committee (ACIP) inactivated hepatitis B virus vaccine. Morbidity and Mortality Weekly Report 1982, 31:317-322.
17. Centers for Disease Control and Prevention Recommendations of the Immunization Practices Advisory Committee (ACIP): Update on hepatitis B prevention 1987.
18. Centers for Disease Control and Prevention Recommendations of the Immunization Practices Advisory Committee prevention of perinatal transmission of hepatitis B virus: Prenatal screening of all pregnant women for hepatitis B surface antigen 1988.
19. Centers for Disease Control and Prevention Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination - recommendations of the Immunization Practices Advisory Committee (ACIP) 1991.
20. Centers for Disease Control and Prevention Notice to readers update: Recommendations to prevent hepatitis B virus transmission - United States 1995.
21. Centers for Disease Control and Prevention Notice to readers: Recommended childhood immunization schedule - United States, 2002 2002, 31-33. ACIP (Ed.).
22. Centers for Disease Control and Prevention HPV and Cancer 2013, http://www.cdc.gov/hpv/cancer.html.
23. Clarke A.E., Casper M.J. From simple technology to complex arena: classification of pap smears. Medical Anthropology Quarterly 1996, 10:601-623.
24. Biomedicalization: Technoscience, health, and illness in the U.S 2010, Duke University Press, Durham, NC. A.E. Clarke, L. Mamo, J. Fishman, J. Fosket, J. Shim (Eds.).
25. Clifford G., Franceschi S., Diaz M., Munoz N., Villa L. HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006, 24:34.
26. Colgrove J. State of immunity: The politics of vaccination in twentieth-century America 2006, University of California Press, Berkeley, California.
27. Colgrove J., Abiola S., Mello M.M. HPV vaccination mandates - lawmaking amid political and scientific controversy. New England Journal of Medicine 2010, 363:785-791.
28. Conis E. Calling the shots: A social history of vaccination in the us, 1968-2008. History of health Sciences 2010, UCSF, San Francisco, CA.
29. Conis E. "Do we really need hepatitis B on the second day of life?" vaccination mandates and shifting representations of hepatitis B. Journal of Medical Humanities 2011, 32:155-166.
30. Conrad P. The shifting engines of medicalization. Journal of Health and Social Behavior 2005, 46:3-14.
31. Darden P.M., Thompson D.M., Roberts J.R., Hale J.J., Pope C., Naifeh M., et al. Reasons for not vaccinating adolescents: national immunization survey of teens, 2008-2010. Pediatrics 2013, 131:645-651.
32. Doebbeling B.N., Ferguson K.J., Kohout F.J. Predictors of hepatitis B vaccine acceptance in health care workers. Medical Care 1996, 34:58-72.
33. Dumit J. Drugs for life 2012, Duke University Press, Durham, North Carolina.
34. Durst M., Gissmann L., Ikenberg H., Zur Hausen H. Apapillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proceedings of the National Academy of Science USA 1983, 80:3812-3815.
35. Ecks S. Pharmaceutical citizenship: antidepressant marketing and the promise of demarginalization in India. Anthropology & Medicine 2005, 12:239-254.
36. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 2557-2576.
37. Epstein S. Impure science: AIDS, activism, and the politics of knowledge 1996, Berkeley, University of California Press.
38. Epstein S. The great undiscussable: anal cancer, HPV, and gay men's health. Three shots at prevention: The HPV vaccine and the politics of medicine's simple solution 2010, 61-90. Johns Hopkins University Press, Baltmore. K. Wailoo, J. Livingston, S. Epstein, R. Aronowitz (Eds.).
39. Epstein S., Huff A. Sex, science, and the politics of biomedicine: Gardasil in comparative perspective. Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions 2010, 213-228. The Johns Hopkins University Press, Baltimore, Maryland. K. Wailoo, J. Livingston, S. Epstein, R. Aronowitz (Eds.).
40. Fields J. Risky lessons: Sex education and social inequality 2008, Rutgers University Press, New Brunswick, N.J.
41. Fosket J.R. Breast cancer risk as disease: biomedicalizing risk. Biomedicalization: Technoscience, health and illness in the U.S 2010, Duke University Press, Durham, N.C. A. Clarke, L. Mamo, J.R. Fishman, J. Ruth Fosket, J. Shim (Eds.).
42. Foucault M. The history of sexuality: An introduction 1980, Vol. I. Vintage Books, New York.
43. Frost L.J., Reich M.R. Access: How do good health technologies get to poor people in poor countries? 2009, Harvard University Press.
44. Giuliano A.R., Lee J.-H., Fulp W., Villa L.L., Lascano E., Papenfuss M.R., et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study 2011, 377:932-940.
45. Haraway D.J. Modest_Witness at Second_Millennium.FemaleMan©_Meets_Onco Mouse: Feminism and technoscience 1997, Routledge, New York.
46. Hepatitis Vaccine Approved by FDA The advocate 1982, 8.
47. Hogarth S., Hopkins M.M., Rodriguez V. Amolecular monopoly? HPV testing, the pap smear and the molecularisation of cervical cancer screening in the USA. Sociology of Health and Illness 2012, 34:234-250.
48. Irvine J.M. Talk about sex: The battles over sex education in the United States 2006, University of California Press, Berkeley, CA.
49. Jemal A., Simard E.P., Dorell C., Noone A.-M., Markowitz L.E., Kohler B., et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. Journal of the National Cancer Institute 2013, 105(3):175-201.
50. Krueger H., Gallagher R., Stuart G., Kerner J., Williams D. HPV and other infectious agents in cancer: Opportunities for prevention and public health 2010, Oxford University Press.
51. Livingston J. Improvising medicine: An African oncology ward in an emerging cancer epidemic 2012, Duke University Press, Durham, North Carolina.
52. Lock M. Cultivating the body: anthropology and epistemologies of bodily practice and knowledge. Annual Review of Anthropology 1993, 22:133-155.
53. Löwy I. HPV vaccination in context: a view from France. Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions 2010, 270-292. The Johns Hopkins University Press, Baltimore, Maryland. K. Wailoo, J. Livingston, S. Epstein, R. Aronowitz (Eds.).
54. Löwy I. Awoman's disease: The history of cervical cancer 2011, Oxford University Press, Oxford.
55. Lowy D.R., Schiller J.T. Prophylactic human papillomavirus vaccines. The Journal of Clinical Investigation 2006, 1167-1173.
56. Mamo L., Epstein S. The new sexual politics of cancer: from oncoviruses to sexual health. Presented at a workshop on "Debating causation: Risk, biology, self, and environment in cancer epistemology, 1950-2000." 2011, Princeton University, History of Science Program, 21-22 October 2011.
57. Mamo L., Nelson A., Clark A. Producing and protecting risky girlhoods. Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions 2010, 121-145. The Johns Hopkins University Press, Baltimore, Maryland. K. Wailoo, J. Livingston, S. Epstein, R. Aronowitz (Eds.).
58. May L. Experts urge immunization for millions facing risk of contracting hepatitis B 1984, Los Angeles Times, Los Angeles, CA.
59. Mello M.M., Abiola S., Colgrove J. Pharmaceutical companies' role in state vaccination policymaking: the case of human papillomavirus vaccination. American Journal of Public Health 2012, 102:893-898.
60. Michielsen P., Ho E. Viral hepatitis B and hepatocellular carcinoma. Acta Gastro-Enterologica Belgica 2011, 71:4-8.
61. Murphy M. Seizing the means of reproduction: Entanglements of feminism, health, and technoscience 2012, Duke University Press, Durham, NC.
62. Niccolai L.M., Russ C., Julian P.J., Hariri S., Sinard J., Meek J.I., et al. Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions. Cancer 2013, 119:3052-3058.
63. No AIDS Cases Associated with Hep B Vaccine Gay Community News 1983, 2.
64. Patton C. Lesbian and gay health care: moving into the '80s. Gay Community News 1982, 7.
65. Perz J.F., Armstrong G.L., Farrington L.A., Hutin Y.J., Bell B.P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology 2006, 45:529-538.
66. Petryna A. Globalizing human subjects research. Global pharmaceuticals: Ethics, markets, practices 2006, Duke University Press Books, Durham, North Carolina. A. Petryna, A. Lakoff, A. Kleinman (Eds.).
67. Petryna A., Kleinman A. The pharmaceutical nexus. Global pharmaceuticals: Ethics, markets, practices 2006, 1-32. Duke University Press Books, Durham, North Carolina. A. Petryna, A. Lakoff, A. Kleinman (Eds.).
68. Pollock A. Pharmaceutical meaning-making beyond marketing: racialized subjects of generic thiazide. The Journal of Law, Medicine, & Ethics 2008, 36:530-536.
69. Pollock A. Medicating race 2012, Duke University Press, Durham, North Carolina.
70. Ramogola-Masire D. Cervical cancer, HIV, and the HPV vaccine in Botswana. Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions 2010, 91-100. The Johns Hopkins University Press, Baltimore, Maryland. K. Wailoo, J. Livingston, S. Epstein, R. Aronowitz (Eds.).
71. Ramqvist T., Dalianis T. Oropharyngeal cancer epidemic and human papillomavirus. Emerging infectious disease 2010, CDC, Atlanta.
72. Results of Hepatitis Vaccine Encourage Health Officials. (1983). New York Times.
73. Rose N. Molecular biopolitics, somatic ethics and the spirit of biocapital. Social Theory & Health 2007, 5:3-29.
74. Shostak S. Locating gene-environment interaction: at the intersections of genetics and public health. Social Science & Medicine 2003, 56:2327-2342.
75. Shostak S. Marking populations and persons at risk: molecular epidemiology and environmental health. Biomedicalization: Technoscientific transformations of health, illness, and U.S. Biomedicine 2010, 242-262. Duke University Press, Durham, North Carolina. A.E. Clarke, K. Shim Janet, L. Mamo, J. Ruth Fosket, J.R. Fishman (Eds.).
76. Taylor N.P. HPV vax awareness uneven despite Merck ad blitz 2013, FierceVaccines.
77. Timmermans S., Buchbinder M. Patients-in-waiting: living between sickness and health in the genomics era. Journal of Health and Social Behavior 2010, 51:408-423.
78. Tsu V., Wittet S. Appropriate human papillomavirus vaccination strategies. Lancet 2009, 374:1327-1328. author reply 1328-1329.
79. United States Food and Drug Administration FDA news release: Gardasil approved to prevent anal cancer 2010.
80. Vargas-Parada L. Pathology: three questions. Nature 2012, 488.
81. Wailoo K. How cancer crossed the color line 2011, Oxford University Press, Oxford, England.
82. Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions 2010, The Johns Hopkins University Press, Baltimore, Maryland. K. Wailoo, J. Livingston, S. Epstein, R. Aronowitz (Eds.).
83. Wallis C. AIDS: A growing threat 1985, Time Magazine.
84. Whitemarsh I. Biomedical ambiguity: Race, asthma, and the contested meaning of genetic research in the Caribbean 2008, Cornell University Press, Ithaca and London.
85. WHO Hepatitis B fact sheet 2012.
86. Williams S.J., Martin P., Gabe J. The pharmaceuticalization of Society? A framework for analysis. Sociology of Health & Illness 2011, 33:710-725.
87. Willis B., Wortley P., Wang S., Jacques-Carroll L., Zhang F. Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus. Pediatrics 2010, 125:704-711.
88. World Health Organization Comprehensive cervical cancer control: A guide to essential practice 2006, 284. World Health Organization, Geneva, Switzerland.
89. Yi D. The enemy within? Oncogenes and the demise of the virus cancer program in the 1970s. Debating causation: Risk, biology, self, and environment in cancer epistemology 2011, 1950-2000. Princeton University.
90. Zur Hausen H. Infections causing human cancer 2006, WILEY-VCH & Co.